Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helle F Jørgensen

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Atherosclerosis|December 21, 2024
Epigenetic regulation of vascular smooth muscle cell phenotypes in atherosclerosisJordi Lambert, Helle F Jørgensen
Nature|September 3, 2010
Can controversies be put to REST?Helle F Jørgensen, Amanda G Fisher
Biochemical Society Transactions|September 8, 2021
Mechanisms of vascular smooth muscle cell investment and phenotypic diversification in vascular diseasesMatthew D Worssam, Helle F Jørgensen
British Journal of Pharmacology|June 30, 2019
The role of smooth muscle cells in plaque stability: Therapeutic targeting potentialJennifer L Harman, Helle F Jørgensen
Cell Stem Cell|March 7, 2009
LOCKing in Cellular PotentialHelle F Jørgensen, Amanda G Fisher
Molecular and Cellular Biology|April 3, 2004
Mbd1 is recruited to both methylated and nonmethylated CpGs via distinct DNA binding domainsHelle F Jørgensen, Ittai Ben-Porath, Adrian P Bird
Nucleic Acids Research|August 9, 2006
Engineering a high-affinity methyl-CpG-binding proteinHelle F Jørgensen, Karen Adie, Pascal Chaubert, et al.
Nature|February 27, 2009
Is REST required for ESC pluripotency?Helle F Jørgensen, Zhou-Feng Chen, Matthias Merkenschlager, et al.
Nature Reviews. Cardiology|June 28, 2019
Vascular smooth muscle cells in atherosclerosisGemma L Basatemur, Helle F Jørgensen, Murray C H Clarke, et al.
Cell Cycle (Georgetown, Tex.)|July 21, 2006
Stem cells primed for action: polycomb repressive complexes restrain the expression of lineage-specific regulators in embryonic stem cellsHelle F Jørgensen, Sara Giadrossi, Miguel Casanova, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Atherosclerosis|December 21, 2024
Epigenetic regulation of vascular smooth muscle cell phenotypes in atherosclerosisJordi Lambert, Helle F Jørgensen
Nature|September 3, 2010
Can controversies be put to REST?Helle F Jørgensen, Amanda G Fisher
Biochemical Society Transactions|September 8, 2021
Mechanisms of vascular smooth muscle cell investment and phenotypic diversification in vascular diseasesMatthew D Worssam, Helle F Jørgensen
British Journal of Pharmacology|June 30, 2019
The role of smooth muscle cells in plaque stability: Therapeutic targeting potentialJennifer L Harman, Helle F Jørgensen
Cell Stem Cell|March 7, 2009
LOCKing in Cellular PotentialHelle F Jørgensen, Amanda G Fisher
Molecular and Cellular Biology|April 3, 2004
Mbd1 is recruited to both methylated and nonmethylated CpGs via distinct DNA binding domainsHelle F Jørgensen, Ittai Ben-Porath, Adrian P Bird
Nucleic Acids Research|August 9, 2006
Engineering a high-affinity methyl-CpG-binding proteinHelle F Jørgensen, Karen Adie, Pascal Chaubert, et al.
Nature|February 27, 2009
Is REST required for ESC pluripotency?Helle F Jørgensen, Zhou-Feng Chen, Matthias Merkenschlager, et al.
Nature Reviews. Cardiology|June 28, 2019
Vascular smooth muscle cells in atherosclerosisGemma L Basatemur, Helle F Jørgensen, Murray C H Clarke, et al.
Cell Cycle (Georgetown, Tex.)|July 21, 2006
Stem cells primed for action: polycomb repressive complexes restrain the expression of lineage-specific regulators in embryonic stem cellsHelle F Jørgensen, Sara Giadrossi, Miguel Casanova, et al.
Pageof 4